P. Schoenfeld Asset Management (PSAM)’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-477,602	Closed	-$378K	–	395
2022 Q1	$378K	Hold	477,602	–	–	0.02%	252
2021 Q4	$287K	Sell	477,602 -96,015	-17%	-$97.5K	0.01%	291
2021 Q3	$545K	Buy	573,617 +83,846	+17%	+$87.4K	0.03%	241
2021 Q2	$725K	Buy	+489,771	New	+$427K	0.04%	232

Other funds holding PEARW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s PEARW Position: Q2 2022 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2022, closing a stake of 477,602 shares — an estimated $378K sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in PEARW in Q2 2021 and held it in 4 quarters. The position peaked at $725K in Q2 2021. 37 funds tracked by Wall St. Rank hold PEARW as of Q2 2022.

P. Schoenfeld Asset Management (PSAM) reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2022 after selling out during the quarter.
P. Schoenfeld Asset Management (PSAM) sold 477,602 Pear Therapeutics, Inc. Warrant shares in Q2 2022, an estimated $378K.
P. Schoenfeld Asset Management (PSAM) first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and held it in 4 quarters.
P. Schoenfeld Asset Management (PSAM)'s Pear Therapeutics, Inc. Warrant position peaked at $725K in Q2 2021.
37 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2022.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q2 2022, filed 15 Aug 2022.